SCHEMBL23851040

SCHEMBL23851040

Nc1cc(C(F)(F)F)ccc1N1CC[C@H](O)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MAPT P10636 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
IDH2 P48735 8/20 0.49
PKM P14618 1/20 0.49
PLA2G7 Q13093 2/20 0.46
MGLL Q99685 2/20 0.46
ABHD6 Q9BV23 2/20 0.46
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LIPG Q9Y5X9 3/20 0.42
LPL P06858 1/20 0.42
PDE3B Q13370 2/20 0.42
PDE3A Q14432 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31588171 1.00 ALDH1A1 (0.57) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL23851042 1.00 ALDH1A1 (0.57) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL31588073 0.92 LMNA (0.65) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL31587375 0.92 LMNA (0.65) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL23850803 0.92 LMNA (0.65) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL23850683 0.92 LMNA (0.65) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL23850685 0.92 LMNA (0.65) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL31588198 0.88 ALDH1A1 (0.59) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL23850602 0.88 ALDH1A1 (0.59) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL1410343 0.84 LMNA (0.55) ALDH1A1LMNAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883650-A1 COMPOUNDS Grey Wolf Therapeutics Limited (GB) 2021-09-29 EP disclosed
CN-113056305-A Compound (I) 格雷沃尔夫治疗有限公司 2021-06-29 CN disclosed